- Home
- ORIC vs CRMD Comparison
ORIC vs CRMD Comparison
Compare ORIC & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORIC | CRMD |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 958.1M |
| IPO Year | 2020 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ORIC | CRMD |
|---|---|---|
| Price | $12.06 | $7.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 7 |
| Target Price | ★ $19.73 | $15.29 |
| AVG Volume (30 Days) | 1.8M | ★ 4.2M |
| Earning Date | 02-17-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.25 |
| Revenue | N/A | ★ $214,303,672.00 |
| Revenue This Year | N/A | $629.55 |
| Revenue Next Year | N/A | $8.34 |
| P/E Ratio | ★ N/A | $3.44 |
| Revenue Growth | N/A | ★ 1647.67 |
| 52 Week Low | $3.90 | $5.60 |
| 52 Week High | $14.93 | $17.43 |
Technical Indicators
Market Signals| Indicator | ORIC | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 68.34 | 37.32 |
| Support Level | $11.52 | $7.15 |
| Resistance Level | $12.61 | $7.59 |
| Average True Range (ATR) | 0.83 | 0.55 |
| MACD | 0.33 | -0.02 |
| Stochastic Oscillator | 86.92 | 24.45 |
Price Performance
Historical ComparisonAbout ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.